Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dana-Farber/Brigham and Women's Cancer Center includes some of the world's top researchers and clinicians in hepatocellular carcinoma, the most common type of primary liver cancer. Staffed by medical, surgical, and radiation oncologists, we offer the latest treatments fueled by ongoing research and discovery.
Our dedicated experts work together across a range of specialty areas to coordinate fully integrated, personalized care. Team members are actively involved in research to advance the treatment options and our understanding of this disease.
In addition to a multidisciplinary group of physicians, your treatment team includes physician assistants (PAs), nurse practitioners (NPs), and clinical and research nurses. Laboratory investigators, clinical care coordinators, clinical social workers, and nutritionists are also integral members of your care team.
Learn more about our liver cancer specialists.
New Patient Appointments